S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Keros Therapeutics Inc

Follow

0

Keros Therapeutics Inc

Follow

0

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

TheFinalCD

01/15/25 6:45 AM

Re: #2: @Monksdream - KROS more upside possible

$KROS halts all dosing in the TROPOS Phase 2 clinical trial of cibotercept (KER-012) based on the ongoing safety review due to new observations of pericardial effusion adverse events

https://x.com/BioStocks/status/1879492237891080688

$KROS the TROPOS trial is being terminated early. The Co continues to expect to present topline data from all treatment arms in this trial in Q2
https://x.com/BioStocks/status/1879493199288586404

retireat40

12/18/24 5:30 PM

Wow. What a turd

retireat40

12/17/24 5:54 PM

Re: #3: @Dennis14 - Bought in at 18.00

Shocked this is still sub 18

Dennis14

12/12/24 1:03 PM

Bought in at 18.00

Monksdream

09/14/24 6:26 PM

Re: #1: @Monksdream - KROS new 52=week high

KROS more upside possible

Monksdream

02/24/24 3:42 PM

KROS new 52=week high

Keros Therapeutics Inc (KROS)

Followers	0	Posters	4
Posts (Today)	0	Posts (Total)	6
Created	02/24/24	Type	Free
Moderators

Moderators' Board Intro has not been added

Volume:
Day Range:
Last Trade Time:

Delayed by 15 minutes

1D
1M
3M
6M
1Y
5Y

KROS Latest News

Form 8-K - Current report
01/21/2025 08:01:40 AM
Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept
01/21/2025 08:00:00 AM
Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS Trial
01/15/2025 06:30:00 AM

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow